Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01994603 · ClinicalTrials.gov registry record · NA
Expansion to Interdisciplinary HIV Prevention in Women
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT01994603: Completed NA study, sponsored by University of Oklahoma.
NCT01994603 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01994603, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This trial will pilot test intervention strategies to increase utilization of HIV testing and gain knowledge for designing a clinical trial to evaluate prevention strategies to reduce HIV sexual transmission in the general population in Russia. The study will assess whether external (cost, convenience) or internal factors (low perception of own risk, reluctance to identify a partner as at-risk, fear of stigma) drive Russian women's reluctance to be tested and if peer support impacts their decision. A randomized experimental manipulation, comparing opt-in vs. bundled opt-out testing approaches, followed by focus group discussions, followed by a second-chance testing offer will be used to inform these questions. The answers will enable the international research team to engineer and then test an HIV testing promotion strategy in Russia. The project will collect preliminary data for a larger study to develop an evidence-based program to reduce the HIV transmission in this high risk population.
Primary Outcome
A brief survey completed over the phone. Participants asked when the last HIV test was completed and her reasons for taking the test.
Interventions
- BEHAVIORAL Focus Group
- BEHAVIORAL Opt-in or Opt-out testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-09 |
| Phase | NA |
What the finished NCT01994603 record still lists
NCT01994603 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Focus Group is the first listed.
NCT01994603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01994603 about?
NCT01994603 is a clinical study titled "Expansion to Interdisciplinary HIV Prevention in Women". This trial will pilot test intervention strategies to increase utilization of HIV testing and gain knowledge for designing a clinical trial to evaluate prevention strategies to reduce HIV sexual transmission in the general population in Russia. The study will assess whether external (cost, convenien...
What is the current status of trial NCT01994603?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2012-12. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01994603?
The interventions under investigation include: Focus Group (BEHAVIORAL), Opt-in or Opt-out testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT01994603?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01994603's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia